Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (11): 1036-1040.doi: 10.3736/jcim20101106
• Original Expreimental Research • Previous Articles Next Articles
Hong Liu a,Guo-liang Zhanga,Li Shenb,Zhen Zengb,Bao-luo Zhou c,Cheng-hai Liub,Guang Niea
[1] |
Sanders DA . No false start for novel pseudotyped vectors[J]. Curr Opin Biotechnol, 2002,13(5):437-442
doi: 10.1016/S0958-1669(02)00374-9 pmid: 12459334 |
[2] |
Giroglou T, Cinatl J Jr, Rabenau H, Drosten C, Schwalbe H, Doerr HW, von Laer D .Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein[J]. J Virol, 2004,78(17):9007-9015
doi: 10.1128/JVI.78.17.9007-9015.2004 pmid: 15308697 |
[3] |
Tsai C, Caillet C, Hu H, Zhou F, Ding H, Zhang G, Zhou B, Wang S, Lu S, Buchy P, Deubel V, Vogel FR, Zhou P . Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase[J]. Vaccine, 2009,27(48):6777-6790
doi: 10.1016/j.vaccine.2009.08.056 |
[4] | Zhang DF. Pharmacology and experimental pharmacology of Chinese materia medica[M]. Shanghai: Shanghai Scientific and Technical Publishers, 2002: 8-9 |
张大方 . 药理与中药药理实验[M]. 上海: 上海科学技术出版社, 2002: 8-9 | |
[5] |
Wang SY, Su CY, Lin M, Huang SY, Huang WI, Wang CC, Wu YT, Cheng TJ, Yu HM, Ren CT, Wu CY, Wong CH, Cheng YS . HA-pseudotyped retroviral vectors for influenza antagonist screening[J]. J Biomol Screen, 2009,14(3):294-302
doi: 10.1177/1087057108330786 pmid: 19211776 |
[6] | Huang H, Feng MQ, Sun CW, Xu SG, Pu JX, Zhou P . Anti-influenza virus activity of Yinqin capsules[J]. Fu Dan Xue Bao Yi Xue Ban, 2006,33(4):517-521 |
黄海, 冯美卿, 孙传文, 徐树光, 普俊学, 周珮 . 银芩胶囊抗流感病毒的活性[J]. 复旦学报(医学版), 2006,33(4):517-521 | |
[7] |
Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, Voss G, Goepfert P, Gilbert P, Greene KM, Bilska M, Kothe DL, Salazar-Gonzalez JF, Wei X, Decker JM, Hahn BH, Montefiori DC . Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies[J]. J Virol, 2005,79(16):10108-10125
doi: 10.1128/JVI.79.16.10108-10125.2005 |
[8] | Yan KX, Tan WJ, Zhang XM, Wang HJ, Li Y, Ruan L . Development and application of a safe SARS-CoV neutralization assay based on lentiviral vectors pseudotyped with SARS-CoV spike protein[J]. Bing Du Xue Bao, 2007,23(6):440-446 |
闫克夏, 谭文杰, 张相民, 王慧娟, 李岩, 阮力 . SARS-CoV假病毒中和试验技术的建立及评价[J]. 病毒学报, 2007,23(6):440-446 | |
[9] |
Bartosch B, Dubuisson J, Cosset FL . Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes[J]. J Exp Med, 2003,197(5):633-642
doi: 10.1084/jem.20021756 |
[10] |
Liu HL, Rong LJ, Zhou B, Wei JC, Zheng QS, Chen FY. Characterization of murine leukemia virus recombinants that express H5N1 subtype avian influenza virus hemagglutinin glycoproteins[J]. Sheng Wu Gong Cheng Xue Bao,2005,21(1):47-51
doi: 10.3321/j.issn:1000-3061.2005.01.009 |
刘华雷, Rong LJ, 周斌, 魏建超, 郑其升, 陈溥言 . 表达H5N1亚型禽流感病毒HA蛋白的重组鼠白血病病毒的特性[J].生物工程学报, 2005,21(1):47-51
doi: 10.3321/j.issn:1000-3061.2005.01.009 |
|
[11] |
Zhang GL, Zhou BP, Chen XC, Cai CG, Lu J, Yang GL, Nie G, Zhou BL . Construction of pseudotype retrovirus which integrates hemagglutinin of H5N1 avian influenza virus isolated from human in Shenzhen[J]. Zhonghua Wei Sheng Wu Xue He Mian Yi Xue Za Zhi, 2009,29(1):53-57
doi: 10.3760/cma.j.issn.0254-5101.2009.01.013 |
张国良, 周伯平, 陈心春, 蔡车国, 陆坚, 杨桂林, 聂广, 周保罗 . 整合深圳人源H5N1禽流感病毒株血凝素蛋白的假型逆转录病毒的构建[J]. 中华微生物学和免疫学杂志, 2009,29(1):53-57
doi: 10.3760/cma.j.issn.0254-5101.2009.01.013 |
|
[12] |
Yang DG, Gao X, Zhou BP, Lu J, Liu ST, Zhang GL, Nie G . Treatment of one severe H5N1 avian influenza case with integrated Chinese and Western medicine[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2007,27(3):280-281
doi: 10.3321/j.issn:1003-5370.2007.03.035 |
杨大国, 高雪, 周伯平, 陆坚, 刘水腾, 张国良, 聂广 . 中西医结合治疗重症H5N1人禽流感1例[J]. 中国中西医结合杂志, 2007,27(3):280-281
doi: 10.3321/j.issn:1003-5370.2007.03.035 |
|
[13] |
Quan FS, Compans RW, Cho YK, Kang SM . Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection[J]. Vaccine, 2007,25(2):272-282
doi: 10.1016/j.vaccine.2006.07.041 |
No related articles found! |